Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Not applicable Interventional Results available

Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

ClinicalTrials.gov ID: NCT05093504

Public ClinicalTrials.gov record NCT05093504. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safe & Timely Antithrombotic Removal-Direct Oral Anticoagulants (STAR-D): Prospective, Multicenter, Double-blind, Randomized Study of Apixaban & Rivaroxaban Removal to Reduce Risk of Serious Bleeding in Urgent Cardiac Surgery Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Prospective, Multicenter, Double-blind, Randomized, Study to Evaluate DrugSorb-ATR Removal of Apixaban and Rivaroxaban to Reduce Likelihood of Serious Bleeding in Patients Undergoing Urgent Cardiothoracic Surgery

Study identification

NCT ID
NCT05093504
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
CytoSorbents, Inc
Industry
Enrollment
9 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 27, 2021 (Actual)
Primary completion
Jan 29, 2024 (Actual)
Completion
Jan 29, 2024 (Actual)
Last update posted
May 4, 2025

2021 – 2024

United States locations

U.S. sites
27
U.S. states
20
U.S. cities
25
Facility City State ZIP Site status
University of California, Davis Medical Center Sacramento California 95817 —
University of Colorado Denver Colorado 80045 —
Yale University New Haven Connecticut 06510 —
Baptist Hospital of Miami and its Miami Cardiac and Vascular Institute Miami Florida 33176 —
Advent Health Orlando Florida 32803 —
University of South Florida Tampa Florida 33606 —
Emory University Hospital Midtown/Emory School of Medicine Atlanta Georgia 30308 —
Emory Saint Joseph's Hospital Atlanta Georgia 30342 —
Lutheran Medical Group Fort Wayne Indiana 46804 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Henry Ford Health System Detroit Michigan 48202 —
University of Mississippi Jackson Mississippi 39216 —
St. Luke's Hospital of Kansas City Kansas City Missouri 64111 —
Bryan Medical Center Lincoln Nebraska 68506 —
Virtua Health Marlton New Jersey 08053 —
Jersey Shore University Medical Center Neptune City New Jersey 07753 —
NYU Langone Medical Center New York New York 10016 —
Bethesda North Hospital, TriHealth, Inc Cincinnati Ohio 45242 —
University Hospitals, Cleveland Medical Center Cleveland Ohio 44106 —
Rhode Island Hospital Providence Rhode Island 02903 —
Medical University of South Carolina Charleston South Carolina 29425 —
Baylor Scott & White The Heart Hospital Plano Texas 75093 —
VCU Medical Center Richmond Virginia 23219 —
University of Wisconsin - Madison Madison Wisconsin 53792 —
The Medical College of Wisconsin, Inc. Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05093504, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2025 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05093504 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →